Statistics
Publications
1
Citations
27
H-Index
1
Active since
2008
Affiliations
Johnson & Johnson (United States)(Current)
Daniel Belajic is an author at Johnson & Johnson (United States) specializing in b-raf inhibitors, molecular oncology, and targeted cancer therapy.
Publications per year
2008–2008
1
1
Shelby Crawford, Daniel Belajic, Jianmei Wei et al. · Molecular Cancer Therapeutics · 2008 · 27 citations · Full text
Medicine, Oncology, Pharmacology +16
1–1 of 1